Category Archives: Services
Service businesses do not fail because of a lack of visibility. They fail when demand arrives at the wrong moment or in the wrong form. This case study shows what happens when marketing is designed around how real customers decide, … Continue reading
Triple Negative Breast Cancer Pipeline Insight A growing number of innovative therapies for triple-negative breast cancer (TNBC) – including TECENTRIQ (Hoffmann-La Roche), IPI-549 (Infinity Pharmaceuticals), Leronlimab (CytoDyn), MDNA11 (Medicenna Therapeutics), VIP236 (Vincerx Pharma), and CFI-400945 (Treadwell Therapeutics) – are expected … Continue reading
Colorectal Cancer Competitive Landscape Leading companies active in the colorectal cancer space include Nektar Therapeutics, ALX Oncology Inc., Processa Pharmaceuticals, Guojian Pharmaceutical, Gritstone Bio, Daiichi Sankyo, Novartis Pharmaceuticals, Shanghai Henlius Biotech, Sumitomo Pharma Oncology, Purple Biotech Ltd., Amgen, Mirati Therapeutics, … Continue reading
Muscle Invasive Bladder Cancer Competitive Landscape Leading companies operating in the Muscle Invasive Bladder Cancer (MIBC) space include Merck Sharp & Dohme LLC, Aura Biosciences, Janssen Research & Development, LLC, Asieris Pharmaceuticals, RemeGen Co., Ltd., along with several other global … Continue reading
Severe Asthma Clinical Trial Prominent companies actively shaping the severe asthma treatment space include Kinaset Therapeutics, Bio-Thera Solutions, CSPC ZhongQi Pharmaceutical Technology, AB Science, GlaxoSmithKline, Oneness Biotech, Biosion, Lanier Biotherapeutics, Kymera Therapeutics, Suzhou Connect Biopharmaceuticals, Upstream Bio, Teva Branded Pharmaceutical … Continue reading
Obesity Clinical Trial Landscape Broadens With 100+ Novel Therapies, Says DelveInsight
Obesity Clinical Trial Major companies active in the obesity space include Pfizer, Biolingus, Regor Pharmaceuticals, Zealand Pharma, Sirnaomics, Innovent Biologics, PegBio, NodThera Limited, Sciwind Biosciences, Boehringer Ingelheim, Clearmind Medicine, Sparrow Pharmaceuticals, Genexine, TransThera, Fractyl Health, Shionogi, among others. As per … Continue reading
DelveInsight’s, “B-cell Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading
DelveInsight’s, “EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC) pipeline landscape. It covers the EGFR + NSCLC … Continue reading
DelveInsight’s “Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading
DelveInsight’s, “Systemic Lupus Erythematosus Pipeline Insights 2025” report provides comprehensive insights about 120+ companies and 140+ pipeline drugs in Systemic Lupus Erythematosus pipeline landscape. It covers the Systemic Lupus Erythematosus pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading
